Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - KIWA BIO-TECH PRODUCTS GROUP CORPFinancial_Report.xls
EX-31.1 - EXHIBIT 31.1 - KIWA BIO-TECH PRODUCTS GROUP CORPv378395_31-1.htm
EX-31.2 - EXHIBIT 31.2 - KIWA BIO-TECH PRODUCTS GROUP CORPv378395_31-2.htm
EX-32.1 - EXHIBIT 32.1 - KIWA BIO-TECH PRODUCTS GROUP CORPv378395_32-1.htm
10-Q - FORM 10-Q - KIWA BIO-TECH PRODUCTS GROUP CORPv378395_10q.htm

Exhibit 32.2

 

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

     In connection with the Quarterly Report of Kiwa Bio-Tech Products Group Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven Ning Ma, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

 (1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period presented therein.

 

Date: May 20, 2014

 

 

 
   
  By:  /s/ Steven Ning Ma  
   

Steven Ning Ma

Principal Financial Officer and Principal Accounting Officer